N-(2-chloropropionyl)piperidine | 115871-51-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: N-(2-chloropropionyl)piperidine
• 英文别名: N-2-chloropropanoylpiperidine；2-Chlorpropionsaeure-piperidid；1-(2-Chloropropanoyl)piperidine；2-chloro-1-piperidin-1-ylpropan-1-one
• CAS: 115871-51-7
• 化学式: C₈H₁₄ClNO
• mdl: MFCD03987973
• 分子量: 175.658
• InChiKey: KQDJFMIFLYHGOL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.875
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  N-(2-chloropropionyl)piperidine 在 甲醇 作用下， 反应 0.5h， 以99%的产率得到哌啶盐酸盐
  参考文献：
  名称：

  A new reagent for the selective, high-yield N-dealkylation of tertiary amines: improved syntheses of naltrexone and nalbuphine

  摘要：

  DOI：

  10.1021/jo00185a072
• 作为产物：
  描述：

  1,6-bis(2-chlorophenyl)-1,6-diphenylhexa-2,4-diyne-1,6-diol;2-chloro-1-piperidin-1-ylpropan-1-one 生成 N-(2-chloropropionyl)piperidine
  参考文献：
  名称：

  TODA, FUMIO;TANAKA, KOITI

  摘要：

  DOI：

文献信息

• Mild, powerful, and robust methods for esterification, amide formation, and thioesterification between acid chlorides and alcohols, amines, thiols, respectively
  作者：Hidefumi Nakatsuji、Mami Morimoto、Tomonori Misaki、Yoo Tanabe

  DOI：10.1016/j.tet.2007.08.117

  日期：2007.11

  practical methods for esterification, amide formation, and thioesterification between acid chlorides and alcohols, amines, thiols, respectively. The present mild and robust reaction was performed by two separate methods both by combining cheap and readily available amines, N-methylimidazole, and N,N,N′,N′-tetramethylethylenediamine (TMEDA). Method A uses catalytic N-methylimidazole and TMEDA with an

  我们开发了两种有效的实用方法，分别用于酰氯与醇，胺，硫醇之间的酯化，酰胺形成和硫酯化。本发明的温和而稳固的反应是通过两种单独的方法进行的，两者都是通过组合廉价且容易获得的胺，N-甲基咪唑和N，N，N '，N'-四甲基乙二胺（TMEDA）。方法A使用等摩尔量的K 2 CO 3催化N-甲基咪唑和TMEDA ，而方法B使用等摩尔量的N-甲基咪唑和TMEDA。其主要特征如下。（i）就反应性而言，方法B在酯化和硫代酯化方面优于方法A，而经济高效的方法A在酰胺形成方面优于方法B。（ii）酰氯与较少亲核和立体拥挤的胺（如2,6-二氯苯胺）之间的酰胺形成过程顺利进行。（iii）该方案适用于成功合成两种农用化学品，溴丁酸酯和杀虫剂。
• Synthesis and antiarrhythmic activity of new benzofuran derivatives
  作者：Guy Bourgery、Philippe Dostert、Alain Lacour、Michel Langlois、Bernard Pourrias、Jacky Tisne-Versailles

  DOI：10.1021/jm00134a007

  日期：1981.2

  Various 5-aminobenzofuran derivatives were prepared from khellin and screened intravenously in the dog for their potential antiarrhythmic activity against ouabain-induced ventricular arrhythmia and in the Harris test. From systematic structural variations it was found that two methoxy groups in positions 4 and 7 on the benzofuran ring, a tertiary aminoethoxy side chain in position 6, and a N-methylurea

  从海尔琳制备了各种5-氨基苯并呋喃衍生物，并在狗中静脉筛选了它们对哇巴因诱导的心律失常的潜在抗心律不齐活性，并在哈里斯试验中进行了筛选。从系统的结构变化中发现，苯并呋喃环的4和7位上的两个甲氧基，6位的叔氨基乙氧基侧链和5位的N-甲基脲基团导致活性最高。然后在狗的哈里斯测试中对它们进行口服测试。两个长效衍生物N- [4,7-二甲氧基-6-（2-吡咯烷基乙氧基）-5-苯并呋喃基] -N'-甲基脲（8j）和N- [4,7-二甲氧基-6-（2-哌啶基乙氧基）-5-苯并呋喃基] -N'-甲基脲（8m）与奎尼丁和二吡酰胺相比具有优势，已被选择作进一步研究。
• Synthesis, Cytotoxicity by Bioluminescence Inhibition, Antibacterial and Antifungal Activity of ([1,2,4]Triazolo[1,5-<i>c</i>]quinazolin-2-ylthio)carboxylic Acid Amides
  作者：Lyudmila N. Antipenko、Alexander V. Karpenko、Sergey I. Kovalenko、Andrew M. Katsev、Elena Z. Komarovska-Porokhnyavets、Vladimir P. Novikov

  DOI：10.1002/ardp.200900077

  日期：2009.11

  We report in this work the synthesis, cytotoxicity, and antimicrobial activity of ([1,2,4]triazolo[1,5‐c]quinazolin‐2‐ylthio)carboxylic acid amides 4–7 in connection with our previous research in the preparation of triazoloquinazoline derivatives. Due to simplicity, general availability of starting materials, and high yields, the most reliable method of synthesis appeared to be the one with N,N‐carbonyldiimidazole

  我们在这项工作中报告了（[1,2,4]三唑并[1,5-c]喹唑啉-2-基硫基）羧酸酰胺 4-7 的合成、细胞毒性和抗菌活性，这与我们之前在三唑并喹唑啉衍生物的制备。由于简单、原料普遍可用和收率高，最可靠的合成方法似乎是具有 N,N-羰基二咪唑活化阶段的合成方法。所有获得的物质的化学结构都是从 FT-IR、1H-NMR、EI-MS 和 LC-MS 光谱数据推导出来的。通过生物发光抑制细菌 Photobacterium leiognathi Sh1 菌株评估的细胞毒性结果表明，化合物 4.1、4.6 和 6.1 的细胞毒性最强。通过硬板琼脂扩散法对酰胺 4-7（浓度 5 mg/mL）的抗菌和抗真菌活性进行了研究。我们发现这些化合物对细念珠菌具有低 (4.1, 4.7) 抗真菌活性，对黑曲霉具有强 (4.21, 5.1, 5.9) 或低效 (4.7, 4.12, 4.16) 活性。物质 5.1 和
• Selective Estrogen Receptor Modulator
  申请人：Hamaoka Shinichi

  公开号：US20120004315A1

  公开（公告）日：2012-01-05

  The present invention provides a compound represented by the following formula (I); [wherein T represents a single bond, a C1-C4 alkylene group which may have a substituent and the like; formula (I-1) represents a single bond or a double bond; A represents a single bond, a bivalent 5- to 14-membered heterocyclic group which may have a substituent and the like; Y represents a single bond and the like; Z represents a methylene group and the like; ring G represents a phenylene group and the like which may condense with a 5- to 6-membered ring and may have a heteroatom; R a and R b are the same as or different from each other and represent a hydrogen atom and the like; W represents a single bond and the like; R′ represents 1 to 4 independent hydrogen atoms and the like; and R″ represents 1 to 4 independent hydrogen atoms and the like] or a salt thereof, or a hydrate thereof.

  本发明提供一种由以下式（I）表示的化合物; [其中T表示单键，可能具有取代基的C1-C4烷基和类似物；式（I-1）表示单键或双键；A表示单键，可能具有取代基的双价5-至14-成员杂环基和类似物；Y表示单键和类似物；Z表示亚甲基基团和类似物；环G表示苯基团和类似物，可能与5-至6-成员环缩合并可能具有杂原子；Ra和Rb相同或不同，表示氢原子和类似物；W表示单键和类似物；R'表示1到4个独立的氢原子和类似物；R''表示1到4个独立的氢原子和类似物]或其盐或水合物。
• Selective estrogen receptor modulator
  申请人：Hamaoka Shinichi

  公开号：US20060116364A1

  公开（公告）日：2006-06-01

  The present invention provides a compound represented by the following formula [wherein T represents a single bond, a C1-C4 alkylene group which may have a substituent and the like; formula (I-1) represents a single bond or a double bond; A represents a single bond, a bivalent 5- to 14-membered heterocyclic group which may have a substituent and the like; Y represents a single bond and the like; Z represents a methylene group and the like; ring G represents a phenylene group and the like which may condense with a 5- to 6-membered ring and may have a heteroatom; R a and R b are the same as or different from each other and represent a hydrogen atom and the like; W represents a single bond and the like; R′ represents 1 to 4 independent hydrogen atoms and the like; and R″ represents 1 to 4 independent hydrogen atoms and the like] or a salt thereof, or a hydrate thereof

  本发明提供了一种化合物，其表示为以下式子[其中T表示单键，C1-C4的烷基，可能带有取代基等；式(I-1)表示单键或双键；A表示单键，二价的5-至14-成员杂环基团，可能带有取代基等；Y表示单键等；Z表示亚甲基等；环G表示苯基团等，可与5-至6-成员环缩合并且可能具有杂原子；Ra和Rb相同或不同，表示氢原子等；W表示单键等；R'表示1至4个独立的氢原子等；R"表示1至4个独立的氢原子等]或其盐，或其水合物。